ArticleCureus2026
Clinicopathological and Radiological Profile of Gallbladder Carcinoma: A Cross-Sectional Study From a Tertiary Care Center in Tripura, India.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Gallbladder carcinoma is an aggressive malignancy with marked geographic variation in incidence within India, particularly affecting the northern and northeastern regions. Given the limited evidence from Tripura, this study aimed to describe the clinicopathological and radiological profile of gallbladder carcinoma patients presenting to a tertiary care center in Tripura, India. Methods A prospective, hospital-based, cross-sectional study was conducted in the Department of General Surgery, Agartala Government Medical College and Govind Ballabh Pant Hospital (AGMC & GBPH), Agartala, India, from May 2024 to November 2025. All patients with a confirmed diagnosis of gallbladder carcinoma during the study period were eligible. Of 123 diagnosed patients, 104 were included after applying the exclusion criteria. Data were collected using a structured proforma covering sociodemographic characteristics, clinical presentation, laboratory parameters, radiological findings, histopathology, and tumor staging. Staging was performed according to the American Joint Committee on Cancer (AJCC) 8th edition classification. Data were analyzed using IBM SPSS Statistics for Windows, Version 26 (Released 2018; IBM Corp., Armonk, NY, USA). Results The mean age of participants was 61.4 ± 8.8 years, with more than half of the participants (n = 59, 56.7%) aged over 60 years. A marked female predominance was observed (n = 92, 88.5%). Most patients belonged to lower socioeconomic strata (n = 52, 50.0%) and resided in rural areas (n = 78, 75%). Abdominal pain was the most common presenting symptom, while icterus was the most frequent clinical sign. Elevated carbohydrate antigen 19-9 (CA 19-9) was observed among 69 (66.3%) patients, and elevated carcinoembryonic antigen (CEA) levels were observed in 77 (74%) patients. On ultrasonography (USG), a gallbladder mass was detected in 82 (78.8%) cases, while contrast-enhanced computed tomography (CECT) identified mass lesions in 94 (90.4%) cases. Histopathologically, adenocarcinoma was the predominant subtype, with well-differentiated tumors accounting for 41 (39.4%) cases. Advanced disease at presentation was frequent, with T3-T4 tumors in 72 (69.2%) patients, nodal involvement in 67 (64.4%), and distant metastasis in 28 (26.9%) patients. Stage IVB was the most common AJCC stage (n = 42, 40.4%). Conclusion Gallbladder carcinoma patients in Tripura predominantly present with advanced-stage disease and exhibit a strong female preponderance. The high burden of locoregional and metastatic spread underscores the need for region-specific awareness, earlier diagnostic strategies, and strengthened referral pathways to improve outcomes in this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.